Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
Authors
Keywords
-
Journal
Cancer Discovery
Volume 13, Issue 2, Pages 496-515
Publisher
American Association for Cancer Research (AACR)
Online
2022-11-11
DOI
10.1158/2159-8290.cd-21-0218
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Equivalent Carbon Number and Interclass Retention Time Conversion Enhance Lipid Identification in Untargeted Clinical Lipidomics
- (2022) Jake B. White et al. ANALYTICAL CHEMISTRY
- Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia
- (2022) Mahmoud A. Bassal et al. Nature Communications
- Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation
- (2021) Yongjie Ma et al. ONCOGENE
- Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia
- (2021) Lucille Stuani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia
- (2021) Brooks A. Benard et al. Nature Communications
- Lipid Mass Spectrometry: A Path Traveled for 50 Years
- (2020) Robert C. Murphy JOURNAL OF MASS SPECTROMETRY
- Lipid Annotator: Towards Accurate Annotation in Non-Targeted Liquid Chromatography High-Resolution Tandem Mass Spectrometry (LC-HRMS/MS) Lipidomics Using a Rapid and User-Friendly Software
- (2020) Jeremy P. Koelmel et al. Metabolites
- Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
- (2020) Lisa M. Butler et al. ADVANCED DRUG DELIVERY REVIEWS
- Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
- (2019) Matthew J. Watt et al. Science Translational Medicine
- Identification of bioactive metabolites using activity metabolomics
- (2019) Markus M. Rinschen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors
- (2019) Bin Fan et al. INVESTIGATIONAL NEW DRUGS
- Challenges and Opportunities in Cancer Metabolomics
- (2019) Ashish Kumar et al. PROTEOMICS
- Metabolomics for Investigating Physiological and Pathophysiological Processes
- (2019) David S. Wishart PHYSIOLOGICAL REVIEWS
- Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study
- (2019) Maeve A Lowery et al. Lancet Gastroenterology & Hepatology
- Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin
- (2019) Julia Biedermann et al. Cancers
- Metabolomics and Isotope Tracing
- (2018) Cholsoon Jang et al. CELL
- NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction
- (2018) Edoardo Gaude et al. MOLECULAR CELL
- Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
- (2018) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Wild-type and mutated IDH1/2 enzymes and therapy responses
- (2018) Remco J. Molenaar et al. ONCOGENE
- Consumption of NADPH for 2-HG Synthesis Increases Pentose Phosphate Pathway Flux and Sensitizes Cells to Oxidative Stress
- (2018) Susan J. Gelman et al. Cell Reports
- Lack of evidence for substrate channeling or flux between wildtype and mutant isocitrate dehydrogenase to produce the oncometabolite 2-hydroxyglutarate
- (2018) Joseph P. Dexter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
- (2018) Daniel A. Pollyea et al. NATURE MEDICINE
- Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells
- (2018) Mehmet G. Badur et al. Cell Reports
- Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells
- (2018) Mehmet G. Badur et al. Cell Reports
- A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML
- (2017) L M Kats et al. LEUKEMIA
- Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data
- (2017) Subarna Sinha et al. Nature Communications
- Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120
- (2016) K.C. Birendra et al. Clinical Lymphoma Myeloma & Leukemia
- Reductive carboxylation supports redox homeostasis during anchorage-independent growth
- (2016) Lei Jiang et al. NATURE
- Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models
- (2016) Robert U Svensson et al. NATURE MEDICINE
- Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
- (2016) M. Konopleva et al. Cancer Discovery
- Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML
- (2015) Courtney D. DiNardo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
- (2015) Steven M Chan et al. NATURE MEDICINE
- Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells
- (2015) Luyuan Li et al. PLoS One
- Derivatization of the tricarboxylic acid intermediates with O-benzylhydroxylamine for liquid chromatography–tandem mass spectrometry detection
- (2014) Bo Tan et al. ANALYTICAL BIOCHEMISTRY
- IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism
- (2014) A. R. Grassian et al. CANCER RESEARCH
- IDH mutations in liver cell plasticity and biliary cancer
- (2014) Supriya K Saha et al. CELL CYCLE
- Quantitative flux analysis reveals folate-dependent NADPH production
- (2014) Jing Fan et al. NATURE
- Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
- (2014) Daniel Ackerman et al. TRENDS IN CELL BIOLOGY
- Oxidation of Alpha-Ketoglutarate Is Required for Reductive Carboxylation in Cancer Cells with Mitochondrial Defects
- (2014) Andrew R. Mullen et al. Cell Reports
- Position of the Academy of Nutrition and Dietetics: Nutritional Genomics
- (2014) Kathryn M. Camp et al. Journal of the Academy of Nutrition and Dietetics
- Differential isotope dansylation labeling combined with liquid chromatography mass spectrometry for quantification of intact and N-terminal truncated proteins
- (2013) Yanan Tang et al. ANALYTICA CHIMICA ACTA
- The fat side of prostate cancer
- (2013) Giorgia Zadra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
- (2013) F. Baenke et al. Disease Models & Mechanisms
- Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
- (2013) Walter G. Park et al. GASTROINTESTINAL ENDOSCOPY
- Fatty Acid Labeling from Glutamine in Hypoxia Can Be Explained by Isotope Exchange without Net Reductive Isocitrate Dehydrogenase (IDH) Flux
- (2013) Jing Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TOFA suppresses ovarian cancer cell growth in vitro and in vivo
- (2013) SHU LI et al. Molecular Medicine Reports
- LipidBlast in silico tandem mass spectrometry database for lipid identification
- (2013) Tobias Kind et al. NATURE METHODS
- Fatty acid metabolism: Implications for diet, genetic variation, and disease
- (2013) Janel Suburu et al. Food Bioscience
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation
- (2012) Roberta Leonardi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Opiate-induced changes in brain adenosine levels and narcotic drug responses
- (2012) M. Wu et al. NEUROSCIENCE
- Identification of drug targets by chemogenomic and metabolomic profiling in yeast
- (2012) Manhong Wu et al. Pharmacogenetics and Genomics
- Reductive carboxylation supports growth in tumour cells with defective mitochondria
- (2011) Andrew R. Mullen et al. NATURE
- Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
- (2011) Christian M. Metallo et al. NATURE
- Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation
- (2010) W. C. Chou et al. BLOOD
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- IDH mutations in glioma and acute myeloid leukemia
- (2010) Lenny Dang et al. TRENDS IN MOLECULAR MEDICINE
- Acetyl-CoA carboxylase-α inhibitor TOFA induces human cancer cell apoptosis
- (2009) Chun Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- Quantifying Reductive Carboxylation Flux of Glutamine to Lipid in a Brown Adipocyte Cell Line
- (2008) Hyuntae Yoo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search